Literature DB >> 32654397

Targeting hepatocyte carbohydrate transport to mimic fasting and calorie restriction.

Jacqueline Kading1, Brian N Finck2, Brian J DeBosch1,3.   

Abstract

The pervasion of three daily meals and snacks is a relatively new introduction to our shared experience and is coincident with an epidemic rise in obesity and cardiometabolic disorders of overnutrition. The past two decades have yielded convincing evidence regarding the adaptive, protective effects of calorie restriction (CR) and intermittent fasting (IF) against cardiometabolic, neurodegenerative, proteostatic, and inflammatory diseases. Yet, durable adherence to intensive lifestyle changes is rarely attainable. New evidence now demonstrates that restricting carbohydrate entry into the hepatocyte by itself mimics several key signaling responses and physiological outcomes of IF and CR. This discovery raises the intriguing proposition that targeting hepatocyte carbohydrate transport to mimic fasting and caloric restriction can abate cardiometabolic and perhaps other fasting-treatable diseases. Here, we review the metabolic and signaling fates of a hepatocyte carbohydrate, identify evidence to target the key mediators within these pathways, and provide rationale and data to highlight carbohydrate transport as a broad, proximal intervention to block the deleterious sequelae of hepatic glucose and fructose metabolism.
© 2020 Federation of European Biochemical Societies.

Entities:  

Keywords:  ChREBP; GLUT; caloric restriction; fibroblast growth factor 21; fructose; glucokinase; intermittent fasting; ketogenic diet; mitochondrial pyruvate carrier; trehalose

Mesh:

Substances:

Year:  2020        PMID: 32654397      PMCID: PMC8662989          DOI: 10.1111/febs.15482

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.622


  125 in total

1.  Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.

Authors:  Anamitra Ghosh; Trevor Tyson; Sonia George; Erin N Hildebrandt; Jennifer A Steiner; Zachary Madaj; Emily Schulz; Emily Machiela; William G McDonald; Martha L Escobar Galvis; Jeffrey H Kordower; Jeremy M Van Raamsdonk; Jerry R Colca; Patrik Brundin
Journal:  Sci Transl Med       Date:  2016-12-07       Impact factor: 17.956

2.  Aldolase-B knockout in mice phenocopies hereditary fructose intolerance in humans.

Authors:  Sarah A Oppelt; Erin M Sennott; Dean R Tolan
Journal:  Mol Genet Metab       Date:  2015-01-22       Impact factor: 4.797

3.  Differential expression of genes and changes in glucose metabolism in the liver of liver-specific glucokinase gene knockout mice.

Authors:  Rong Wang; Hui Gao; Wei Xu; Hui Li; Yiqing Mao; Yi Wang; Tingting Guo; Xi Wang; Rongjing Song; Zhixin Li; David M Irwin; Gang Niu; Huanran Tan
Journal:  Gene       Date:  2013-01-02       Impact factor: 3.688

4.  Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice.

Authors:  Miguel A Lanaspa; Ana Andres-Hernando; David J Orlicky; Christina Cicerchi; Cholsoon Jang; Nanxing Li; Tamara Milagres; Masanari Kuwabara; Michael F Wempe; Joshua D Rabinowitz; Richard J Johnson; Dean R Tolan
Journal:  J Clin Invest       Date:  2018-04-23       Impact factor: 14.808

5.  Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride Content.

Authors:  Nynke Simons; François-Guillaume Debray; Nicolaas C Schaper; M Eline Kooi; Edith J M Feskens; Carla E M Hollak; Lucas Lindeboom; Ger H Koek; Judith A P Bons; Dirk J Lefeber; Leanne Hodson; Casper G Schalkwijk; Coen D A Stehouwer; David Cassiman; Martijn C G J Brouwers
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

6.  Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  Kyle S McCommis; Wesley T Hodges; Elizabeth M Brunt; Ilke Nalbantoglu; William G McDonald; Christopher Holley; Hideji Fujiwara; Jean E Schaffer; Jerry R Colca; Brian N Finck
Journal:  Hepatology       Date:  2017-03-30       Impact factor: 17.425

7.  Lactotrehalose, an Analog of Trehalose, Increases Energy Metabolism Without Promoting Clostridioides difficile Infection in Mice.

Authors:  Yiming Zhang; Nurmohammad Shaikh; Jeremie L Ferey; Umesh D Wankhade; Sree V Chintapalli; Cassandra B Higgins; Jan R Crowley; Monique R Heitmeier; Alicyn I Stothard; Belgacem Mihi; Misty Good; Takanobu Higashiyama; Benjamin M Swarts; Paul W Hruz; Kartik Shankar; Phillip I Tarr; Brian J DeBosch
Journal:  Gastroenterology       Date:  2019-12-12       Impact factor: 22.682

Review 8.  Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies.

Authors:  Christophe Kosinski; François R Jornayvaz
Journal:  Nutrients       Date:  2017-05-19       Impact factor: 5.717

9.  Hepatocyte ALOXE3 is induced during adaptive fasting and enhances insulin sensitivity by activating hepatic PPARγ.

Authors:  Cassandra B Higgins; Yiming Zhang; Allyson L Mayer; Hideji Fujiwara; Alicyn I Stothard; Mark J Graham; Benjamin M Swarts; Brian J DeBosch
Journal:  JCI Insight       Date:  2018-08-23

10.  Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.

Authors:  Panu K Luukkonen; Sylvie Dufour; Kun Lyu; Xian-Man Zhang; Antti Hakkarainen; Tiina E Lehtimäki; Gary W Cline; Kitt Falk Petersen; Gerald I Shulman; Hannele Yki-Järvinen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

View more
  3 in total

1.  SIRT1 selectively exerts the metabolic protective effects of hepatocyte nicotinamide phosphoribosyltransferase.

Authors:  Cassandra B Higgins; Allyson L Mayer; Yiming Zhang; Michael Franczyk; Samuel Ballentine; Jun Yoshino; Brian J DeBosch
Journal:  Nat Commun       Date:  2022-02-28       Impact factor: 14.919

2.  Hepatic Suppression of Mitochondrial Complex II Assembly Drives Systemic Metabolic Benefits.

Authors:  Xueqiang Wang; Weiqiang Lv; Jie Xu; Adi Zheng; Mengqi Zeng; Ke Cao; Xun Wang; Yuting Cui; Hao Li; Meng Yang; Yongping Shao; Fang Zhang; Xuan Zou; Jiangang Long; Zhihui Feng; Jiankang Liu
Journal:  Adv Sci (Weinh)       Date:  2022-01-17       Impact factor: 16.806

3.  Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism.

Authors:  Yiming Zhang; Cassandra B Higgins; Brian A Van Tine; John S Bomalaski; Brian J DeBosch
Journal:  Cell Rep Med       Date:  2022-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.